Hutch News

Hutch News

Stories tagged 'antibiotic resistance'

Flu season tips for cancer patients

It’s bad out there. Here are 7 things you need to know to protect yourself — and others

Feb. 6, 2018 | By Mary Engel / Fred Hutch News Service

7 things cancer and other immunocompromised patients should know about this year's flu season.

View story >


When bad bugs jump from farm to bedside

‘Big Chicken’ author, infectious disease researchers take aim at antibiotic resistance driven by agriculture, medicine

Jan. 26, 2018 | By Mary Engel / Fred Hutch News Service

At Fred Hutch's 'Farm to Bedside' symposium, infectious disease experts from around the state took aim at antibiotic resistance.

View story >


Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech

Fred Hutch experts lend their predictions for the coming year’s advances

Jan. 12, 2018 | By Rachel Tompa / Fred Hutch News Service

We asked Fred Hutch researchers for their predictions on scientific advances to watch in the coming year. Look for their tips on what's next in cancer immunotherapy, precision oncology, gene editing, infectious disease research, cancer prevention and more.

View story >


Antimicrobial stewardship preserves a ‘shared resource’

Gains in cancer survival at risk due to surge in multi-drug resistant superbugs

May 4, 2017 | By Mary Engel / Fred Hutch News Service

Antibiotics and other antimicrobials are unique among medications, a “shared resource” that we need to preserve, much as we steward our environment and natural resources, says Fred Hutch clinician-infectious disease researcher Dr. Catherine Liu. Overuse or misuse can lead to drug-resistant bugs that can then spread to new hosts and in some cases even spread their resistance genes to different microorganisms, posing a risk to society at large.

View story >


Super drugs for superbugs: Creative ways to combat antibiotic resistance

New discoveries could overcome antibiotic development stalemate, stay ahead of bacteria’s steady march toward drug resistance

Jan. 15, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

New discoveries could overcome antibiotic development stalemate and stay ahead of bacteria’s steady march toward drug resistance.

View story >


Smith antibiotics study wins Gates grant

The $100,000 one-year grant will fund the development of a new class of antimicrobial drugs to treat TB and limit the evolution of resistance to antibiotics

May 11, 2009 | By Dean Forbes

A project by the Fred Hutchinson Cancer Research Center's Dr. Gerald Smith to find new antibiotics to treat TB and to simultaneously limit the evolution of resistance to antibiotics was selected for funding by the Bill & Melinda Gates Foundation Grand Challenges in Global Health. The $100,000, one-year grant was one of 81 awarded by the organization worldwide in early May.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.